Literature DB >> 32454689

Determination of Potential Drug-Drug Interactions Using Various Software Programs in a Community Pharmacy Setting.

Mesut Sancar1, Aksa Kaşik1, Betül Okuyan1, Sevda Batuhan1, Fikret Vehbi Izzettin2.   

Abstract

OBJECTIVES: The aim of the present study was to compare various software programs in detecting potential drug-drug interactions in a community pharmacy setting.
MATERIALS AND METHODS: Details of prescriptions were collected from 50 community pharmacies located in İstanbul in March and April 2015 (two days per week). From each pharmacy, the first 20 prescriptions that included more than one drug were collected to evaluate potential drug-drug interactions. The following software programs were utilized to detect potential drug-drug interactions: micromedexsolutions.com, medscape.com, and drugs.com. The number of potential interactions detected by the software programs was determined.
RESULTS: At least one potential drug-drug interaction was detected in 39.2% of the 1000 prescriptions by one of the software programs. According to the rates of total drug-drug interactions gathered from various software programs, these programs gave the following results: medscape.com 33.3%, drugs.com 31.3%, and micromedexsolutions.com 21.2%.
CONCLUSION: After comparing different software programs, the potential drug-drug interactions found by the programs proved to be different. Therefore, we recommend that pharmacists confirm with a different program before making a decision when they detect clinically significant potential drug-drug interactions. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  Drug–drug interactions; community pharmacy; pharmacist; software programs

Year:  2018        PMID: 32454689      PMCID: PMC7227974          DOI: 10.4274/tjps.30932

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  19 in total

1.  Suspected adverse drug events requiring emergency department visits or hospital admissions.

Authors:  R Raschetti; M Morgutti; F Menniti-Ippolito; A Belisari; A Rossignoli; P Longhini; C La Guidara
Journal:  Eur J Clin Pharmacol       Date:  1999-02       Impact factor: 2.953

2.  Quality of drug interaction alerts in prescribing and dispensing software.

Authors:  Michelle Sweidan; James F Reeve; Jo-anne E Brien; Pradeep Jayasuriya; Jennifer H Martin; Graeme M Vernon
Journal:  Med J Aust       Date:  2009-03-02       Impact factor: 7.738

3.  Assessment of the consistency among three drug compendia in listing and ranking of drug-drug interactions.

Authors:  Božana S Nikolić; Maja S Ilić
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

4.  Evaluation of frequently used drug interaction screening programs.

Authors:  Priska Vonbach; André Dubied; Stephan Krähenbühl; Jürg H Beer
Journal:  Pharm World Sci       Date:  2008-04-16

5.  Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.

Authors:  E L Olvey; S Clauschee; D C Malone
Journal:  Clin Pharmacol Ther       Date:  2009-11-04       Impact factor: 6.875

6.  Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources.

Authors:  Maria A P Martins; Paula P S Carlos; Daniel D Ribeiro; Vandack A Nobre; Cibele C César; Manoel O C Rocha; Antonio L P Ribeiro
Journal:  Eur J Clin Pharmacol       Date:  2011-06-24       Impact factor: 2.953

7.  Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.

Authors:  Richard T Scheife; Lisa E Hines; Richard D Boyce; Sophie P Chung; Jeremiah D Momper; Christine D Sommer; Darrell R Abernethy; John R Horn; Stephen J Sklar; Samantha K Wong; Gretchen Jones; Mary L Brown; Amy J Grizzle; Susan Comes; Tricia Lee Wilkins; Clarissa Borst; Michael A Wittie; Daniel C Malone
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

8.  Recommendations for generating, evaluating, and implementing drug-drug interaction evidence.

Authors:  Lisa E Hines; Daniel C Malone; John E Murphy
Journal:  Pharmacotherapy       Date:  2012-04       Impact factor: 4.705

9.  Management of drug-interaction alerts in community pharmacies.

Authors:  J Indermitte; M Beutler; R Bruppacher; C R Meier; K E Hersberger
Journal:  J Clin Pharm Ther       Date:  2007-04       Impact factor: 2.512

10.  Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature.

Authors:  Verena Bergk; Walter E Haefeli; Christiane Gasse; Hermann Brenner; Meret Martin-Facklam
Journal:  Eur J Clin Pharmacol       Date:  2005-06-28       Impact factor: 2.953

View more
  5 in total

1.  Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study.

Authors:  Afraa Abbas; Samaher Al-Shaibi; Sowndramalingam Sankaralingam; Ahmed Awaisu; Vyas S Kattezhathu; Supakit Wongwiwatthananukit; Yaw B Owusu
Journal:  Int J Clin Pharm       Date:  2021-11-23

2.  Influence of Pharmacy Characteristics and Customer Quality of Life on Satisfaction of Community Pharmacy Customers.

Authors:  Ali Azeez Al-Jumaili; Inaam Ahmed Ameen; Doaa Asaad Alzubaidy
Journal:  Innov Pharm       Date:  2020-02-19

3.  Analysis of interaction risks of patients with polypharmacy and the pharmacist interventions performed to solve them-A multicenter descriptive study according to medication reviews in Hungarian community pharmacies.

Authors:  András Szilvay; Orsolya Somogyi; Annamária Dobszay; Attiláné Meskó; Romána Zelkó; Balázs Hankó
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

4.  Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece.

Authors:  Marios Spanakis; Maria Melissourgaki; George Lazopoulos; Athina E Patelarou; Evridiki Patelarou
Journal:  Pharmaceutics       Date:  2021-02-09       Impact factor: 6.321

5.  Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.

Authors:  Michael Hecker; Niklas Frahm; Paula Bachmann; Jane Louisa Debus; Marie-Celine Haker; Pegah Mashhadiakbar; Silvan Elias Langhorst; Julia Baldt; Barbara Streckenbach; Felicita Heidler; Uwe Klaus Zettl
Journal:  Front Pharmacol       Date:  2022-08-05       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.